ABC | Volume 115, Nº2, August 2020

Short Editorial Roque Which Risk Score Best Assesses Clinical Objectives in Patients with Arq Bras Cardiol. 2020; 115(2):205-206 1. Braunwald E (2012).  “Hypertrophic cardiomyopathy: The first century 1869-1969”. Glob Cardiol Sci Pract. 2012 (1):5 2. Evans W. “Familial cardiomegaly”. Br Heart J.1949; 11(1):68-82.  3. Pare JA, Fraser RG, Pirozynski WJ,Shanks JA, Stubington D.  “Hereditary cardiovascular dysplasia. A formof familial cardiomyopathy”. Am J Med. 31: 37–62.. 4. Teare D. “Asymmetrical hypertrophy of the heart in young adults”. Br Heart J. 1958;20(1):1-8. 5. Brock R.  “Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis)”. Guys Hosp Rep.1959;108:126-43. 6. Maron BJ (2003).  “Sudden death in young athletes”.  N Engl J Med. 349(11):1064-75. 7. Shiozaki AA, Senra T, Arteaga E, Pita CG, Martinelli Filho M, Avila LF, et al. Myocardial fibrosis in patients with hypertrophic cardiomyopathy and high risk for sudden death. Arq Bras Cardiol.2010;94(4):535-40. 8. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. American College of Cardiology Foundation/American Heart Association task force on practice guidelines; AmericanAssociation for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart RhythmSociety; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy executive summary: a report of the American College of Cardiology Foundation/AmericanHeart Association task force on practice guidelines. Circulation.2011;124(24):2761-96. 9. O’Mahony C, Jichi F, PavlouM, Monserrat L, Anastasakis A, Rapezzi C, et al. Hypertrophic cardiomyopathy outcomes investigators. A novel clinical risk predictionmodel for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J.2014;35(30):2010-20. 10. Moons k, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009 Jun 04;338:b606 doi: 10.1136/bmj.b606 11. Mattos BP, Scolari FL,Garbin HI . Discrepancy between International Guidelines on the Criteria for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. Arq Bras Cardiol. 2020; 115(2):197-204). References This is an open-access article distributed under the terms of the Creative Commons Attribution License 206